Dusabimana et al. [19] found that AKT was activated in the DKD mouse model and subsequently phosphorylated GSK-3β (Ser-9) which was the inhibitory site of GSK-3β, thereby inhibiting GSK-3β activity. The gene discussed is GSK3B; the disease is diabetic kidney disease.